Diehl Linda, Schurich Anna, Grochtmann Regina, Hegenbarth Silke, Chen Lieping, Knolle Percy A
Institute for Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.
Hepatology. 2008 Jan;47(1):296-305. doi: 10.1002/hep.21965.
Liver sinusoidal endothelial cells (LSEC) are unique organ-resident antigen-presenting cells capable of cross-presentation and subsequent tolerization of naïve CD8(+) T cells. We investigated the molecular mechanisms underlying this tolerance induction in naive CD8(+) T cells. MHC class I-restricted antigen presentation by LSEC led to initial stimulation of naïve CD8(+) T cells, which up-regulated CD69, CD25, CD44, and programmed death (PD)-1 and proliferated similar to dendritic cell (DC)-activated CD8(+) T cells. Importantly, cognate interaction with naïve CD8(+) T cells triggered increased expression of co-inhibitory B7-H1 but not co-stimulatory CD80/86 molecules exclusively on LSEC but not DC. This matured phenotype of B7-H1(high) CD80/86(low) was critical for induction of CD8(+) T cell tolerance by LSEC: B7-H1-deficient LSEC, that failed to interact with PD-1 on stimulated T cells, were incapable of inducing CD8(+) T cell tolerance. Moreover, increased costimulation via CD28 interfered with tolerance induction, indicating that the noninducible low expression levels of CD80/86 on LSEC supported B7-H1-dependent tolerance induction. LSEC-tolerized CD8(+) T cells had a distinctive phenotype from naïve and activated T cells with CD25(low), CD44(high), CD62L(high). They also expressed the homeostatic cytokine receptors CD127, CD122, and high levels of Bcl-2, indicating survival rather than deletion of tolerant CD8(+) T cells. On adoptive transfer into congenic animals, tolerized CD8(+) T cells failed to show specific cytotoxicity in vivo.
Cognate interaction of LSEC with naïve CD8(+) T cells elicits a unique tolerogenic maturation of LSEC and permissiveness of T cells for tolerogenic signals, demonstrating that LSEC-induced tolerance is an active and dynamic process.
肝窦内皮细胞(LSEC)是独特的驻器官抗原呈递细胞,能够交叉呈递并随后使幼稚CD8(+) T细胞产生耐受。我们研究了幼稚CD8(+) T细胞中这种耐受诱导的分子机制。LSEC进行的MHC I类限制性抗原呈递导致幼稚CD8(+) T细胞的初始刺激,这些细胞上调CD69、CD25、CD44和程序性死亡(PD)-1,并像树突状细胞(DC)激活的CD8(+) T细胞一样增殖。重要的是,与幼稚CD8(+) T细胞的同源相互作用仅在LSEC而非DC上触发共抑制性B7-H1分子表达增加,而共刺激性CD80/86分子未增加。这种B7-H1(高) CD80/86(低)的成熟表型对于LSEC诱导CD8(+) T细胞耐受至关重要:缺乏B7-H1的LSEC无法与受刺激T细胞上的PD-1相互作用,因而无法诱导CD8(+) T细胞耐受。此外,通过CD28增加共刺激会干扰耐受诱导,表明LSEC上不可诱导的低水平CD80/86表达支持B7-H1依赖性耐受诱导。LSEC诱导耐受的CD8(+) T细胞具有与幼稚和活化T细胞不同的表型,表现为CD25(低)、CD44(高)、CD62L(高)。它们还表达稳态细胞因子受体CD127、CD122以及高水平的Bcl-2,表明耐受的CD8(+) T细胞是存活而非缺失。将耐受的CD8(+) T细胞过继转移到同基因动物体内后,它们在体内未表现出特异性细胞毒性。
LSEC与幼稚CD8(+) T细胞的同源相互作用引发LSEC独特的致耐受性成熟以及T细胞对致耐受性信号的允许性,表明LSEC诱导的耐受是一个活跃且动态的过程。